<elated!>
Genovo, Biogen and Targeted Genetics should make
a very nice team. I've not thought about Genovo
since I was so big into Ariad last year.
I hold a nice core position of Tgen, have been
trying to goof around daytrading the shares too.
I find myself 1500 shares light this morning as
the news breaks, but now, I'm happy to buy those
shares back, even if it is a couple bucks higher.
Bravo!
Now I have to think about Ariad-Genovo again,
how to get the regulation back into the equation.
Maybe Scott can fill us in since he is the big Ariad
fan these days. I'm afraid my brain has entirely
turned to mush--between the daytrades, and of
course the midnight feedings and diaper changes...
if you think my posts are incoherent, you should
hear me talking to the baby all day.
Biogen will end up owning about 9 percent of Targeted
Genetics. The new relationship between the companies will
replace a 1995 agreement between Biogen and Genovo,
Targeted Genetics said. So I guess that means
Ariad is not somehow in the picture?
Thanks to the recent slump in Tgen, Genovo is issued
TGEN at $10, so I should think everybody will be happy.
Of course, not even understanding the science adequately,
I'd have put all of these critters under the same roof
last fall, when BGEN could have done it for a song,
but obviously happy events went differently <g>.
Ah, here is the kick-ass version of the press release
that you snagged, thanks Nigel!
Message 14185398 |
